Reducing coronary risk by raising HDL-cholesterol: risk modelling the addition of nicotinic acid to existing therapy

By Belsey Jonathan   de Lusignan Simon   van Vlymen Jeremy   Chan Tom   Hague Nigel  

Current Medical Research and Opinion, Vol. 24, Iss. 9, 2008-09 ,pp. : 2703-2709

Informa Healthcare

Access to resources Recommend Favorite

Predicted coronary risk for adults with coronary heart disease and low HDL-C: an analysis from the US National Health and Nutrition Examination Survey

By Zhang Bin   Menzin Joe   Friedman Mark   Korn Jonathan R.   Burge Russel T.  

Current Medical Research and Opinion, Vol. 24, Iss. 9, 2008-09 ,pp. : 2711-2717

Informa Healthcare

Access to resources Recommend Favorite

The incremental impact of residual SYNTAX score on long‐term clinical outcomes in patients with multivessel coronary artery disease treated by percutaneous coronary interventions

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 86, Iss. 1, 2015-07 ,pp. : 3-10

John Wiley & Sons Inc

Access to resources Recommend Favorite

Soluble CD40 Ligand as a Predictor of Coronary Artery Disease and Long-Term Clinical Outcomes in Stable Patients Undergoing Coronary Angiography

By  

Cardiology, Vol. 109, Iss. 3, 2007-08 ,pp. : 196-201

Karger

Access to resources Recommend Favorite

Lipoprotein lipase Hin dIII polymorphism influences HDL-cholesterol levels in statin-treated patients with coronary artery disease

By Javorský Martin   Gašperíková Daniela   Ukropec Jozef   Sedláková Barbora   Riečanský Igor   Križanová Ol'ga   Šeböková Elena   Dobríková Martina   Klimeš Iwar   Tkáč Ivan  

Wiener klinische Wochenschrift, Vol. 119, Iss. 15-16, 2007-08 ,pp. : 476-482

Springer Publishing Company

Access to resources Recommend Favorite